Discover how Vysnova, in partnership with NAMRU-2, is pioneering advancements in disease surveillance and control through the SABER II program in Southeast Asia. Learn how their innovative approaches are tackling threats from Malaria to COVID-19 and shaping the future of public health.
This September, join Vysnova Partners in celebrating National Hispanic Heritage Month. Discover how we honor the contributions and diverse heritage of our Hispanic team members in fields like public health, R&D, and government operations.
Vysnova, a Culmen International subsidiary, announces its participation in the 2023 MHSRS at Gaylord Palms Resort, Kissimmee, FL. Dive into the significance of this DoD’s premier scientific meeting and discover Vysnova's commitment to advancing military healthcare.
Uncover how the DRC Cooperative Agreement team, led by Vysnova and in collaboration with the CDC's DRC Country Office and Viral Special Pathogens Branch, is strategizing to enhance public health preparedness and surveillance in the DRC. Learn about the key objectives, the progress made, and the range of concurrent projects being implemented to address potential health threats including Ebola and other VHFs.
Discover how a collaborative effort between Vysnova, the London School of Hygiene and Tropical Medicine (LSHTM), and the Lao National Animal Health Laboratory is tackling the potential pandemic threat posed by emerging strains of Influenza A Viruses (IAV) in Southeast Asia. This case study explores the challenges faced by low- and middle-income countries (LMICs) in the region and highlights the importance of proactive surveillance and research in resource-constrained environments. Learn about the findings from extensive interviews, surveys, and lab work, which aim to characterize the risks associated with novel and emerging influenza strains. Find out how these efforts contribute to global public health by enhancing our understanding of IAV dynamics and developing effective surveillance strategies to mitigate future risks. The article concludes with recommendations for continued strategic collaborations, enhanced surveillance measures, and further research to refine pandemic prevention strategies based on these learnings.
Explore how collaborative efforts between Vysnova, LSHTM, and the Lao National Animal Health Laboratory enhance surveillance of Influenza A Viruses (IAV) in Southeast Asia. This article discusses their strategies to mitigate pandemic risks by understanding the dynamics of IAV and devising effective surveillance systems, particularly in regions with high zoonotic transmission potential.
Vysnova Partners, a Culmen International Company, has been selected to support the National Intrepid Center of Excellence (NICoE) in its mission to improve care for military personnel with traumatic brain injuries and psychological health conditions. This strategic partnership includes the development of a robust Program Management Office, communications plans, and risk management strategies, further enhancing the effectiveness of the NICoE and Defense Intrepid Network's critical work.
Alexandria, Virginia, April 28, 2023—Culmen International is pleased to announce the recent acquisition of Maryland-based Vysnova Partners. With a combined pool of over 400 employees, offices in 37 countries, and experience across more than 140 countries, Culmen International is poised to offer clients a unique set of agile, global resources and expertise.